This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second Take: Discussing targets in TED (IGF-1R, IL-6 & FcRn class), including their available clinical data.

Ticker(s): HZNP, VRDN, IMVT, ARGX

Who's the expert?

Institution: Stanford

  • Assistant professor of ophthalmology at Stanford and Director of the Oculofacial plastic, Reconstructive surgery and Orbital Oncology Eyes Institute at the Byers Eye Institute at Stanford
  • Specializes in aesthetic oculofacial surgery, thyroid eye disease and orbital oncology
  • Research interests include the proteomic evaluation of ocular surface and orbital inflammation, modulation of neural reflexes via neurotization and neurostimulation and evaluating targeted therapies for cutaneous and orbital malignancies

Interview Goal
Discuss various MOAs for treating TED

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.